Zobrazeno 1 - 10
of 3 461
pro vyhledávání: '"H. Takimoto"'
Autor:
M. K. Leabman, G. Hernandez, C. M. Ng, J. Tang, D. Pandya, K. C. Hart, K. Li, P. R. Hinton, J. So, I. Qazi, C. Y. Cheah, W. S. Kim, E. Budde, A. K. Gopal, T. Manley, C. H. Takimoto, A. M. Sinclair, S. F. Carroll, B. A. Keyt, M. F. Kotturi
Publikováno v:
HemaSphere, Vol 6, Pp 1161-1162 (2022)
Externí odkaz:
https://doaj.org/article/0b096a9e042e4b0d89131ab7c9e7b9c8
Autor:
Mark P. Chao, Chris H. Takimoto, Dong Dong Feng, Kelly McKenna, Phung Gip, Jie Liu, Jens-Peter Volkmer, Irving L. Weissman, Ravindra Majeti
Publikováno v:
Frontiers in Oncology, Vol 9 (2020)
In recent years, immunotherapies have been clinically investigated in AML and other myeloid malignancies. While most of these are focused on stimulating the adaptive immune system (including T cell checkpoint inhibitors), several key approaches targe
Externí odkaz:
https://doaj.org/article/8638e8ad243d4633b048ad522ad22867
Publikováno v:
Asian Journal of Atmospheric Environment, Vol 11, Iss 4, Pp 270-282 (2017)
To evaluate the deposition amount on a ground surface, mesoscale numerical models coupled with atmospheric chemistry are widely used for larger horizontal domains ranging from a few to several hundreds of kilometers; however, these models are rarely
Externí odkaz:
https://doaj.org/article/16f0e100e4b84cde8627a37e7c4f56c5
Autor:
Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga
PDF file - 59K, Pharmacodynamic Parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e14cb944d79c031c6011a979c8d4e6
https://doi.org/10.1158/1078-0432.22447530.v1
https://doi.org/10.1158/1078-0432.22447530.v1
Autor:
Chris H. Takimoto, Sridhar Mani, Dale E. Shuster, Mendel Jansen, Fang Fang, Christopher Desjardins, Nancy Wong, Quincy S. Chu, Eric K. Rowinsky, Monica Mita, Alain C. Mita, Sanjay Goel
Editorial on this Article from A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a351f344895b818e22174cb35314bb7
https://doi.org/10.1158/1078-0432.22440229.v1
https://doi.org/10.1158/1078-0432.22440229.v1
Autor:
Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga
PDF file - 56K, Mean Pharmacokinetic Parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727c4c0ce9450476bd0f0d51cbaf033a
https://doi.org/10.1158/1078-0432.22447533
https://doi.org/10.1158/1078-0432.22447533
Autor:
Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga
PDF file - 72K, Most Frequent Adverse Events (≥ 15%, any dose group) by Initial Dose Group (Safety Population)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372cae8dbd0011744274748a2a24fcfc
https://doi.org/10.1158/1078-0432.22447536
https://doi.org/10.1158/1078-0432.22447536
Autor:
Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga
PDF file - 50K, Primary Antibodies Used for Immunohistochemical Staining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538b3b600179b1b5c819848bcd8092b1
https://doi.org/10.1158/1078-0432.22447539
https://doi.org/10.1158/1078-0432.22447539
Autor:
Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga
Purpose: In this first-in-human study of AEE788, a tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR), HER-2, and VEGFR-2, a comprehensive pharmacodynamic program was implemented in addition to the evaluation of safety, pharmacokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fac8cfffc49db97f13c3f603843603
https://doi.org/10.1158/1078-0432.c.6521103
https://doi.org/10.1158/1078-0432.c.6521103
Autor:
Chris H. Takimoto, Sridhar Mani, Dale E. Shuster, Mendel Jansen, Fang Fang, Christopher Desjardins, Nancy Wong, Quincy S. Chu, Eric K. Rowinsky, Monica Mita, Alain C. Mita, Sanjay Goel
Purpose: Eribulin mesylate (E7389), a non-taxane microtubule dynamics inhibitor, is a structurally simplified, synthetic analogue of halichondrin B that acts via a mechanism distinct from conventional tubulin-targeted agents. This phase I study deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a73b8975cba01930f10a01137a7d5fa
https://doi.org/10.1158/1078-0432.c.6517579.v1
https://doi.org/10.1158/1078-0432.c.6517579.v1